21490398|suppression|C0221103^C0728721^C0301625|start=0|end=11|DISO^PHYS
21490398|dual|C1554184|start=15|end=19|CONC
21490398|specificity|C0037791^C1511884|start=20|end=31|CONC
21490398|phosphatase|C1149880|start=32|end=43|PHYS
21490398|hypoxia|C0242184|start=49|end=56|DISO
21490398|increases|C0442805^C0205217|start=57|end=66|CONC
21490398|malignancy|C0006826^C1306459|start=87|end=97|DISO
21490398|cancer cells|C0334227|start=107|end=119|ANAT
21490398|hypoxia|C0242184|start=121|end=128|DISO
21490398|inducible|C0205263|start=129|end=138|CONC
21490398|factor|C1521761^C2827422|start=139|end=145|CONC
21490398|master|C0444649|start=163|end=169|CONC
21490398|transcriptional|C0040649|start=170|end=185|PHYS
21490398|regulator|C1704735^C1704734^C0182953|start=186|end=195|DEVI^CONC
21490398|cellular|C0007634^C0178539|start=203|end=211|PROC^ANAT
21490398|response|C2911692^C1706817^C0871261|start=212|end=220|PHYS^CONC
21490398|altered|C0392747|start=224|end=231|CONC
21490398|oxygen|C2359957^C1547125|start=232|end=238|PHYS^CONC
21490398|levels|C0441889|start=239|end=245|CONC
21490398|protein|C0555903^C1521746|start=258|end=265|PROC^CONC
21490398|elevated|C3163633^C0205250|start=269|end=277|CONC
21490398|solid tumors|C0280100|start=286|end=298|DISO
21490398|poor|C1561558^C2700379^C1561559^C0542537^C0032854^C1547310|start=318|end=322|CONC
21490398|disease outcome|C3542417|start=323|end=338|CONC
21490398|promoting|C0033414|start=342|end=351|ACTI
21490398|tumor progression|C0178874|start=352|end=369|DISO
21490398|metastasis|C2939420^C0027627|start=371|end=381|DISO
21490398|resistance|C0237834^C0683598^C1514892|start=387|end=397|PHYS^ACTI
21490398|chemotherapy|C0392920^C3665472^C0013217|start=401|end=413|PROC^CONC
21490398|date|C1547350^C1548309^C2348077^C0011008|start=418|end=422|OBJC^CONC
21490398|relationship|C1705630^C3540605^C1706279^C0439849|start=428|end=440|CONC
21490398|show|C1547282|start=548|end=552|CONC
21490398|expression|C0185117^C0017262^C2911684|start=558|end=568|PROC^PHYS^CONC
21490398|mapk|C1150579^C1370600|start=576|end=580|GENE^PHYS
21490398|specific|C0205369^C1552740|start=581|end=589|CONC
21490398|phosphatase|C1149880|start=590|end=601|PHYS
21490398|dual|C1554184|start=602|end=606|CONC
21490398|specificity|C0037791^C1511884|start=607|end=618|CONC
21490398|phosphatase|C1149880|start=619|end=630|PHYS
21490398|dusp2|C1414184|start=634|end=639|GENE
21490398|markedly|C0522501|start=644|end=652|CONC
21490398|reduced|C0392756|start=653|end=660|CONC
21490398|completely|C0205197|start=664|end=674|CONC
21490398|absent|C0332197|start=675|end=681|CONC
21490398|cancers|C0006826|start=696|end=703|DISO
21490398|level|C0456079^C1547707^C0441889|start=717|end=722|GEOG^CONC
21490398|expression|C0185117^C0017262^C2911684|start=726|end=736|PROC^PHYS^CONC
21490398|cancer|C0006826^C1547140^C1306459^C2707253|start=791|end=797|DISO^OCCU^PHYS
21490398|malignancy|C0006826^C1306459|start=798|end=808|DISO
21490398|analysis|C1524024^C0936012^C0002778|start=810|end=818|PROC^CONC
21490398|cancer cell|C0334227|start=828|end=839|ANAT
21490398|lines|C1553412^C1548328^C0205132|start=840|end=845|CONC
21490398|inhibited|C0311403|start=872|end=881|CONC
21490398|dusp2|C1414184|start=882|end=887|GENE
21490398|transcription|C0040649|start=888|end=901|PHYS
21490398|prolonged|C0439590|start=921|end=930|CONC
21490398|phosphorylation|C0031715^C1158886|start=931|end=946|PHYS
21490398|erk|C1366882^C1150579^C1705791^C1333340^C1370600^C1705767|start=950|end=953|GENE^PHYS
21490398|increased|C0442805^C0205217|start=966|end=975|CONC
21490398|dusp2|C1414184|start=1006|end=1011|GENE
21490398|increased drug resistance|C0521857|start=1012|end=1037|DISO
21490398|forced|C0443221^C0441722|start=1060|end=1066|PHEN^CONC
21490398|expression|C0185117^C0017262^C2911684|start=1067|end=1077|PROC^PHYS^CONC
21490398|dusp2|C1414184|start=1081|end=1086|GENE
21490398|hypoxia|C0242184|start=1097|end=1104|DISO
21490398|induced|C0205263|start=1105|end=1112|CONC
21490398|dusp2|C1414184|start=1155|end=1160|GENE
21490398|cancer progression|C1947901^C0178874|start=1168|end=1186|DISO
21490398|tumor regression|C1718423|start=1194|end=1210|PHYS
21490398|markedly|C0522501|start=1215|end=1223|CONC
21490398|increased|C0442805^C0205217|start=1224|end=1233|CONC
21490398|drug sensitivity|C0237865|start=1234|end=1250|PHYS
21490398|mice|C1413131^C1417166|start=1254|end=1258|GENE
21490398|tumor cell lines|C0085983|start=1282|end=1298|ANAT
21490398|variety|C2346866^C1883525|start=1315|end=1322|CONC
21490398|genes|C0017337|start=1326|end=1331|GENE
21490398|involved|C1314939|start=1332|end=1340|CONC
21490398|drug response|C0683154|start=1344|end=1357|PHYS
21490398|angiogenesis|C0302600^C1519670|start=1359|end=1371|DISO^PHYS
21490398|cell survival|C0007620|start=1373|end=1386|PHYS
21490398|apoptosis|C0162638|start=1392|end=1401|PHYS
21490398|dusp2|C1414184|start=1436|end=1441|GENE
21490398|dusp2|C1414184|start=1472|end=1477|GENE
21490398|is a|C1292718|start=1478|end=1482|CONC
21490398|key|C1554080^C1706198|start=1483|end=1486|CONC
21490398|downstream|C0522506|start=1487|end=1497|CONC
21490398|regulator|C1704735^C1704734^C0182953|start=1498|end=1507|DEVI^CONC
21490398|mediated|C0086597|start=1517|end=1525|ACTI
21490398|tumor progression|C0178874|start=1526|end=1543|DISO
21490398|dusp2|C1414184|start=1565|end=1570|GENE
21490398|may|C3812381|start=1581|end=1584|CONC
21490398|represent|C1882932|start=1585|end=1594|ACTI
21490398|novel|C0205314^C0679622|start=1597|end=1602|CONC
21490398|drug target|C0085104|start=1603|end=1614|DEVI
21490398|relevance|C2347946|start=1629|end=1638|CONC
21490398|tumors|C0027651|start=1642|end=1648|DISO
21490398|resistant to|C0332325|start=1649|end=1661|CONC
21490398|conventional|C0439858|start=1662|end=1674|CONC
21490398|chemotherapy|C0392920^C3665472^C0013217|start=1675|end=1687|PROC^CONC
